Brief: Mayne Pharma Announces Outcome Of Litigation And Update On Scheme
Oct 16 (Reuters) - Mayne Pharma Group Ltd MYX.AX: OUTCOME OF LITIGATION AND UPDATE ON SCHEME SUPREME COURT RULES IN FAVOUR OF MAYNE PHARMA REFERS TO ITS PROPOSED ACQUISITION BY COSETTE PHARMACEUTICALS SCHEME AWAITS FIRB AND SUPREME COURT APPROVAL SHARES TO BE SUSPENDED FROM TRADING ON 23 OCT SUPREME COURT OF NEW SOUTH WALES DISMISSED COSETTE'S CLAIMS Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)